Qi Guo Selected Research

Nontuberculous Mycobacterium Infections

1/2021	Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity.
1/2021	MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection.
1/2020	Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qi Guo Research Topics

Disease

39	Neoplasms (Cancer) 05/2022 - 10/2002
17	Breast Neoplasms (Breast Cancer) 02/2022 - 12/2004
16	Hypertension (High Blood Pressure) 01/2022 - 08/2009
11	Inflammation (Inflammations) 01/2022 - 05/2012
10	Infections 01/2021 - 01/2009
9	Insulin Resistance 01/2021 - 03/2008
8	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2009
8	Wounds and Injuries (Trauma) 04/2022 - 11/2006
7	Critical Illness (Critically Ill) 01/2022 - 10/2007
6	Osteoporosis 07/2019 - 05/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2017
5	Pneumonia (Pneumonitis) 01/2021 - 08/2014
5	Stroke (Strokes) 01/2019 - 10/2012
4	Cognitive Dysfunction 04/2022 - 03/2017
4	Atrial Fibrillation 03/2022 - 01/2021
4	Obesity 01/2022 - 12/2020
4	Carcinogenesis 01/2022 - 10/2005
4	Myocardial Infarction 08/2021 - 01/2016
4	Neuroinflammatory Diseases 07/2021 - 06/2014
4	Hyperglycemia 02/2021 - 01/2012
4	Confusion (Bewilderment) 07/2020 - 10/2011
4	Type 2 Diabetes Mellitus (MODY) 06/2020 - 01/2012
4	Leukemia 10/2019 - 11/2004
4	Human Influenza (Influenza) 01/2018 - 01/2016
4	Stomach Neoplasms (Stomach Cancer) 07/2016 - 01/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
3	COVID-19 01/2022 - 01/2021
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2018
3	Heart Failure 01/2022 - 01/2016
3	Body Weight (Weight, Body) 07/2021 - 03/2017
3	Nontuberculous Mycobacterium Infections 01/2021 - 01/2020
3	Chronic Renal Insufficiency 12/2020 - 04/2013
3	Non-alcoholic Fatty Liver Disease 01/2020 - 11/2016
3	Lung Diseases (Lung Disease) 12/2019 - 01/2018
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 01/2016
3	Brain Injuries (Brain Injury) 11/2018 - 10/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 12/2013
3	Fibrosis (Cirrhosis) 04/2013 - 09/2007
3	Acute Promyelocytic Leukemia 01/2006 - 11/2004
2	Sarcopenia 01/2022 - 01/2020
2	Nausea 01/2022 - 01/2020
2	Vomiting 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2021
2	Esophageal Neoplasms (Esophageal Cancer) 12/2021 - 12/2013
2	Multiple Sclerosis 07/2021 - 07/2014
2	Kidney Diseases (Kidney Disease) 06/2021 - 11/2017
2	Prediabetic State (Prediabetes) 02/2021 - 10/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2004
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2009
10	Biological ProductsIBA 01/2022 - 12/2017
8	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 01/2016
7	CytokinesIBA 07/2021 - 01/2016
7	VaccinesIBA 05/2021 - 01/2016
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
5	Therapeutic UsesIBA 02/2022 - 08/2014
5	EnzymesIBA 01/2022 - 09/2007
5	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 03/2008
5	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2019
5	Messenger RNA (mRNA)IBA 01/2021 - 09/2007
5	SaltsIBA 01/2020 - 08/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2009
4	Long Noncoding RNAIBA 01/2022 - 01/2019
4	Oxygen (Dioxygen)IBA 01/2022 - 06/2003
4	CreatinineIBA 01/2022 - 07/2017
4	Indicators and Reagents (Reagents)IBA 03/2021 - 10/2012
4	LigandsIBA 01/2021 - 11/2004
4	CollagenIBA 01/2020 - 09/2007
4	AlbuminsIBA 01/2018 - 01/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 12/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2014
3	Scavenger Receptors (Scavenger Receptor)IBA 01/2022 - 01/2019
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2009
3	HDL CholesterolIBA 01/2022 - 09/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2012
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2021
3	Peptides (Polypeptides)IBA 01/2021 - 10/2002
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 01/2009
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2005 - 11/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 04/2013
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 07/2020
2	ApolipoproteinsIBA 01/2022 - 09/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 10/2012
2	ORALIT (ORS)IBA 01/2022 - 01/2022
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 02/2021 - 10/2020

Therapy/Procedure

16	Therapeutics 05/2022 - 01/2014
9	Radiotherapy 01/2022 - 01/2014
8	Drug Therapy (Chemotherapy) 01/2020 - 12/2012
6	Critical Care (Surgical Intensive Care) 01/2022 - 10/2007
4	Length of Stay 03/2022 - 10/2011
3	Catheter Ablation 01/2022 - 05/2013
3	Acupuncture Points (Acupuncture Point) 01/2022 - 12/2020
3	Activities of Daily Living (ADL) 01/2021 - 01/2021
3	Photothermal Therapy 01/2020 - 01/2018
2	Intravenous Administration 10/2022 - 01/2018
2	Lasers (Laser) 05/2022 - 01/2018
2	Renal Dialysis (Hemodialysis) 04/2022 - 01/2022
2	Immunotherapy 08/2021 - 06/2017
2	Ligation 08/2021 - 09/2015